載入中
K Pharma, Inc., headquartered in Minato, Japan, was established in 2016 and operates within the Japanese market. The company is dedicated to the research, development, production, and sale of both regenerative medicines and pharmaceutical products. A key focus within their regenerative medicine efforts involves leveraging disease-specific induced pluripotent stem (iPS) cell technology, primarily to develop treatments for conditions such as spinal cord injuries and cerebral infarctions.
最新資料
¥732
+¥15.00 · +2.09%
盤中時間採用JST。市場資料可能有所延遲。
K Pharma, Inc., headquartered in Minato, Japan, was established in 2016 and operates within the Japanese market. The company is dedicated to the research, development, production, and sale of both regenerative medicines and pharmaceutical products. A key focus within their regenerative medicine efforts involves leveraging disease-specific induced pluripotent stem (iPS) cell technology, primarily to develop treatments for conditions such as spinal cord injuries and cerebral infarctions.
日內區間
目前¥732
52週區間
目前¥732
盤中時間採用JST。市場資料可能有所延遲。
K Pharma, Inc., headquartered in Minato, Japan, was established in 2016 and operates within the Japanese market. The company is dedicated to the research, development, production, and sale of both regenerative medicines and pharmaceutical products. A key focus within their regenerative medicine efforts involves leveraging disease-specific induced pluripotent stem (iPS) cell technology, primarily to develop treatments for conditions such as spinal cord injuries and cerebral infarctions.
日內區間
目前¥732
52週區間
目前¥732
營業利益
淨利
| 項目（JPY） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | — | — | 10億 JPY | — | — |
| 銷貨成本 | — | — | 9000萬 JPY | — | 680.3萬 JPY |
| 毛利 | — | — | 9.1億 JPY | — | −680.3萬 JPY |
| 研究與開發 | — | 4.52億 JPY | — | 1.64億 JPY | 1.35億 JPY |
| 銷售、一般及管理費用 | 9.16億 JPY | 3.79億 JPY | −1000 JPY | 1.69億 JPY | 6797.1萬 JPY |
| 營業費用 | 9.16億 JPY | 8.36億 JPY | 5.44億 JPY | 3.54億 JPY | 2.13億 JPY |
| 利息收入 | 300.3萬 JPY | 26.5萬 JPY | 1.6萬 JPY | 7000 JPY | 1000 JPY |
| 利息支出 | 731.1萬 JPY | — | 1184.9萬 JPY | — | — |
| 折舊和攤銷 | — | — | 1000 JPY | — | 680.3萬 JPY |
| 營業利益 | −9.16億 JPY | −8.36億 JPY | 3.66億 JPY | −3.54億 JPY | −2.19億 JPY |
| 淨利 | −9.93億 JPY | −8.46億 JPY | 2.6億 JPY | −3.92億 JPY | −2.29億 JPY |
公司資料更新於 2026年10月16日。
近期已公布業績
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
